In this episode of the Persevere Podcast, we welcome Cynthia Yee to the show. Cynthia has an extensive background in venture financing and capital investment in the medical device field. In her roles, she has worked with companies through all stages of evolution. At Vensana Capital, Cynthia helps companies tell their story, identify their strengths and weaknesses, and achieve their full potential.
Cynthia gives her take on how entrepreneurs can best prepare for fundraising. She encourages entrepreneurs to do their due diligence to find the appropriate fund partners for their company and start building relationships with them as soon as possible. Cynthia discusses the pros and cons of IPOs, mainly how they can be a distraction for young companies, and she guides us through various approaches for constructing term sheets in venture capital deals.
Cynthia also gives insight into how Vensana conducts its due diligence process and why Vensana prefers to be the lead investor in deals. Cynthia then explains how detailing the path to revenue can be more significant than financial projects for an early-stage company.
To learn more about Vensana Capital, visit https://www.vensanacap.com/.
In this episode of the Persevere Podcast, Patty chats with Chris Berg, a media host, and personality about what it takes to succeed in business and life - including practical tips for overall success and a great morning routine.
In this episode, Patty chats with Mel Stanley about personal branding and setting yourself apart as a confident woman in the business world.
In this episode, Patty and Justin Izzo discuss using analytics to build your pitch deck and fund your startup. Using DocSend's reporting capabilities you will gain insights to help propel your fundraising goals.
In this episode of the Persevere Podcast, Patty interviews Jack Coborn Ellis to discuss the nitty-gritty details of pitching and crafting a story that not only gains the attention of your audience but convinces them to become a supporter as well.
In episode 9, Patty chats with Tom Lemberg, the CEO of Curebase, a leading software platform for decentralized clinical trials.